Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Baby formula gets a boost: can added breast milk sugars improve gut health?

NCT ID NCT06361719

First seen Jan 02, 2026 · Last updated Jun 22, 2026 · Updated 24 times

Summary

This study is testing whether a ready-to-feed infant formula with two added human milk oligosaccharides (2'FL and LNnT) can help healthy Chinese babies develop better gut bacteria and immune systems. About 262 infants will be randomly assigned to receive either the test formula or a standard formula, with a separate group of breastfed babies for comparison. The study will measure changes in gut bacteria and other health markers over the first year of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY INFANTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The International Peace Maternity & Child Health Hospital of China Welfare Institute

    RECRUITING

    Shanghai, China

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

infant formula with 2'FL and LNnT (human milk oligosaccharides)

What this could lead to

If successful, this could show that adding these HMOs to formula supports gut health and immune development similar to breast milk.

What could go wrong

This is an early-stage study in healthy infants, so results may not apply to other populations or show clear benefits. The formula is not a treatment for any disease.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.